drugset / Trial / NCT00318630

The Effect Of AVANDIA On The Late Asthmatic Response

NCT00318630 ↗

Phase 1 Completed 26 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

This study is to investigate the effects of AVANDIA on the asthmatic response.

Timeline

Start
2005-07-22
Primary completion
2006-06-30
Completion
2006-06-30

Outcome

Met primary endpoint

paper The late asthmatic reaction (LAR) change from post saline FEV(1) from 4-10 hrs post allergen on day 28 was statistically significant PMID 19944580 ↗

paper Treatment with a PPARgamma agonist (rosiglitazone) was associated with a modest (15%) reduction in the late asthmatic reaction in the allergen challenge model of asthma. PMID 19944580 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg Oral

Indications